Context: Insurance, not immunity, can propel vaccine makers without leaving potential victims in the lurch.
Issues related to vaccine production:
Arguments opposing indemnification of pharma companies
Arguments favouring indemnification of pharma companies
Way forward
Conclusion: Thus, immunity or indemnification from GoI may not be the most appropriate solution to the dilemma.